Therapeutic Phlebotomy in Patients with Grade 1 Hypertension: A Randomized-Controlled Trial.
Jeitler M, Roth S, Steckhan N, Meier L, Koppold-Liebscher DA, Kandil FI, Ostermann T, Stange R, Kessler CS, Brinkhaus B, Michalsen A.
J Integr Complement Med. 2022 Jun;28(6):530-539. doi: 10.1089/jicm.2021.0396. Epub 2022 Mar 2.
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension.
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, Zhu L, Hu F, Li X, Meng S, Yan R, Zhao S, Onwuka JU, Yang B, Sun D, Zhao Y.
J Am Heart Assoc. 2020 Oct 20;9(19):e016804. doi: 10.1161/JAHA.120.016804. Epub 2020 Sep 25.
Modern Management of Hypertensive Emergencies.
Rossi GP, Rossitto G, Maifredini C, Barchitta A, Bettella A, Cerruti L, Latella R, Ruzza L, Sabini B, Vigolo S, Seccia TM.
High Blood Press Cardiovasc Prev. 2022 Jan;29(1):33-40. doi: 10.1007/s40292-021-00487-1. Epub 2021 Nov 23.
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Curr Probl Cardiol. 2017 Jul;42(7):198-225. doi: 10.1016/j.cpcardiol.2017.03.001. Epub 2017 Mar 8.
Novel blood pressure targets in patients with high-normal levels and grade 1 hypertension: Room for monotherapy?
Volpe M, Gallo G, Tocci G.
Int J Cardiol. 2019 Sep 15;291:105-111. doi: 10.1016/j.ijcard.2019.04.074. Epub 2019 Apr 24.
Effects of aerobic exercise on blood pressure in patients with hypertension: a systematic review and dose-response meta-analysis of randomized trials.
Jabbarzadeh Ganjeh B, Zeraattalab-Motlagh S, Jayedi A, Daneshvar M, Gohari Z, Norouziasl R, Ghaemi S, Selk-Ghaffari M, Moghadam N, Kordi R, Shab-Bidar S.
Hypertens Res. 2024 Feb;47(2):385-398. doi: 10.1038/s41440-023-01467-9. Epub 2023 Oct 23.
Analysis of Medication Prescriptions for Hypertension in a Class 1 and Grade A Hospital in Shanxi Province.
Li Z, Wang S, Ren J, Zhi T, Wang H, Zhu Y, Wang Y, Yao Z, Zhang H, Feng J, Zhang R.
Adv Ther. 2021 Oct;38(10):5100-5115. doi: 10.1007/s12325-021-01869-6. Epub 2021 Aug 19.
Effects of taichi on grade 1 hypertension: A study protocol for a randomized controlled trial.
Lee SH, Kim BJ, Park IH, Hwang EH, Park EJ, Jang I, Hwang MS.
Trials. 2020 Feb 13;21(1):177. doi: 10.1186/s13063-019-4028-6.
Effects of Qingda granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial.
Long LZ, Chu JF, Qu H, Yang QN, Lu Y, Fu CG, Peng J, Chen KJ.
Trials. 2023 Jan 2;24(1):1. doi: 10.1186/s13063-022-07006-0.
Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.
Lee CJ, Hwang J, Kang CY, Kim HC, Ryu DR, Ihm SH, Kim YJ, Shin JH, Pyun WB, Kim C, Park S.
J Hypertens. 2021 Aug 1;39(8):1662-1669. doi: 10.1097/HJH.0000000000002820.
